Owner Novalar Pharmaceuticals, Inc.

Inventors Katz, Howard I.; Weber, Eckard

Agent Houlihan2

Pub. Number AU-B-2005211689

Parent 2001259848

Filing date 26 September 2005

Wipo publication date 13 October 2005

Acceptance publication date 21 February 2008

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61K 31/24 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/417 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/505 (2006.01) - Pyrimidines

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61P 23/02 (2006.01) Anaesthetics

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups